2025-01-22 2026-01-31 true No description of principal activity Acting Office - Tax and Accounts 1.0 16201022 bus:FullAccounts 2025-01-22 2026-01-31 16201022 bus:Micro-entities 2025-01-22 2026-01-31 16201022 bus:AuditExempt-NoAccountantsReport 2025-01-22 2026-01-31 16201022 bus:SmallCompaniesRegimeForAccounts 2025-01-22 2026-01-31 16201022 bus:PrivateLimitedCompanyLtd 2025-01-22 2026-01-31 16201022 2025-01-22 2026-01-31 16201022 2026-01-31 16201022 bus:RegisteredOffice 2025-01-22 2026-01-31 16201022 core:WithinOneYear 2026-01-31 16201022 core:AfterOneYear 2026-01-31 16201022 2024-01-22 16201022 bus:Director1 2025-01-22 2026-01-31 16201022 bus:Director1 2026-01-31 16201022 bus:CompanySecretary1 2025-01-22 2026-01-31 16201022 bus:LeadAgentIfApplicable 2025-01-22 2026-01-31 16201022 2025-01-21 16201022 core:CostValuation core:Non-currentFinancialInstruments 2026-01-31 16201022 core:CostValuation core:Non-currentFinancialInstruments 2025-01-21 16201022 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-01-31 16201022 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16201022 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16201022 core:ShareProfitOrLossIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16201022 core:ProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-01-31 16201022 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-01-31 16201022 core:ForeignExchangeDifferencesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16201022 core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16201022 core:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16201022 core:Non-currentFinancialInstruments 2026-01-31 16201022 core:Non-currentFinancialInstruments 2025-01-21 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 16201022
England and Wales

 

 

 

MAGANDA MEDICAL AESTHETIC LTD


Dormant Accounts
 


Period of accounts

Start date : 22 January 2025

End date : 31 January 2026
 
 
2026
£
 
Current assets 100 
Net current assets/(liabilities) 100 
Total assets less current liabilities 100 
Net assets/(liabilities) 100 
 
Capital and reserves 100 
 



Notes to the Accounts

For the period ended 31 January 2026 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Director's Responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476 of the Companies Act 2006.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Signed on behalf of the board of directors:


---------------------------------------------
Ma Corazon Bobila-Smith
Director

Date approved: 20 October 2026
1